Histomorphology based prediction of p16 immunopositivity and p16/HPV DNA co-positivity in oral squamous cell carcinoma

被引:0
|
作者
Naz, Farhat [1 ]
Tanveer, Nadeem [2 ]
Verma, Hitesh [3 ]
Arava, Sudheer [4 ]
Kakkar, Aanchal [4 ]
Pandey, Shivam [5 ]
Goel, Harsh [1 ]
Ranjan, Amar [1 ]
Chopra, Anita [1 ]
Tanwar, Pranay [1 ]
机构
[1] All India Inst Med Sci, Lab Oncol Unit, DR BRA IRCH, New Delhi, India
[2] Univ Coll Med Sci, Dept Pathol, New Delhi, India
[3] All India Inst Med Sci, Dept Otorhinolaryngol, New Delhi, India
[4] All India Inst Med Sci, Dept Pathol, New Delhi, India
[5] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
Oral squamous Cell Carcinoma; Histomorphology; p16; Immunohistochemistry; HPV DNA PCR; HUMAN PAPILLOMA-VIRUS; RISK HUMAN-PAPILLOMAVIRUS; IN-SITU HYBRIDIZATION; HEAD; NECK; CANCER; IMMUNOHISTOCHEMISTRY; PREVALENCE; LESIONS; ASSOCIATION;
D O I
10.1016/j.anndiagpath.2024.152389
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The histomorphological features predictive of p16 and human papilloma virus (HPV DNA) positivity in oropharyngeal carcinoma have been a matter of much debate. However, only few studies have been done on oral squamous cell carcinoma (OSCC) to correlate the histomorphological features with p16 and HPV DNA positivity. Oral squamous cell carcinoma has distinct etiopathogenesis, treatment and prognosis as compared to oropharyngeal carcinomas. A total of 800 oral squamous cell carcinoma biopsy cases were evaluated for features suggestive of HPV infection like basaloid appearance, absence of stromal reaction, nests and lobules of tumor cells with pushing borders, central necrosis, lympho-epithelial morphology, koilocytes, and non-keratinizing or hybrid morphology. Immunohistochemistry was performed for p16 expression (E6H4 clone, CINtec histology, Roche diagnostics). The cases which showed 2+/3+ (from moderate to high intensity) staining with >75 % cells were considered as p16 immunopositive. All the p16 immunopositive cases were subjected to real-time PCR (polymerase chain reaction) for HPV DNA detection to confirm HPV positivity. A total of 139 (17.37 %) OSCC cases were p16 immunopositive and out of these 104 (104/139, 74.8 %) cases showed HPV-DNA PCR positivity. None of the features were found to be predictive on multivariate logistic regression analysis. However, on bivariable analysis, nest/lobule with pushing border was the only histopathological feature which had a significant correlation with p16 immunopositivity (P value = 0.0001) and p16 and HPV DNA copositivity (P value = 0.0001). (Fisher's exact test -two tailed). To conclude-morphology is not really predictive of HPV positivity in OSCC cases. Only one feature- nests and lobule with pushing border is suggestive on bivariable analysis.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] HPV, p16, and bcl-2 expression in oropharyngeal squamous cell carcinoma
    Zapata, M.
    Muller, S.
    MODERN PATHOLOGY, 2007, 20 : 231A - 231A
  • [22] Time trends in prevalence of p16 positivity and combined HPV/p16 positivity in a large cohort of Danish vulvar cancer patients
    Rasmussen, Christina Louise
    Thomsen, Louise T. T.
    Baandrup, Louise
    Franzmann, Maria Benedicte
    Kjaer, Alexander K. K.
    Larsen, Lise Grupe
    Madsen, Else Mejlgaard
    Salinas, Nadia Margeth Villena
    Schledermann, Doris
    Winberg, Birgitte Hjelm
    Ornskov, Dorthe
    Waldstrom, Marianne
    Kjaer, Susanne K. K.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (11) : 2424 - 2432
  • [23] Clinical Significance of p16 Positive but HPV Negative Oropharyngeal Squamous Cell Carcinoma
    Lewis, J. S., Jr.
    Thorstad, W. L.
    Zhang, J.
    Yip, J. H.
    El Mofty, S. K.
    LABORATORY INVESTIGATION, 2010, 90 : 276A - 276A
  • [24] Human Papillomavirus DNA and p16 Gene in Squamous Cell Lung Carcinoma
    Gatta, Luisa Benerini
    Balzarini, Piera
    Tironi, Andrea
    Berenzi, Angiola
    Benetti, Anna
    Angiero, Francesca
    Grigolato, Piergiovanni
    Dessy, Enrico
    ANTICANCER RESEARCH, 2012, 32 (08) : 3085 - 3089
  • [25] Clinical impact of p16 positivity in nasopharyngeal carcinoma
    Shimizu, Yuri
    Murakami, Naoya
    Mori, Taisuke
    Takahashi, Kana
    Kubo, Yuko
    Yoshimoto, Seiichi
    Honma, Yoshitaka
    Nakamura, Satoshi
    Okamoto, Hiroyuki
    Iijima, Kotaro
    Takahashi, Ayaka
    Kaneda, Tomoya
    Kashihara, Tairo
    Inaba, Koji
    Okuma, Kae
    Nakayama, Yuko
    Igaki, Hiroshi
    Itami, Jun
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2022, 7 (04): : 994 - 1001
  • [26] p16 Not a Prognostic Marker for Hypopharyngeal Squamous Cell Carcinoma
    Wilson, David D.
    Rahimi, Asal S.
    Saylor, Drew K.
    Stelow, Edward B.
    Jameson, Mark J.
    Shonka, David C., Jr.
    Reibel, James F.
    Levine, Paul A.
    Read, Paul W.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (06) : 556 - 561
  • [27] Esophageal Squamous Cell Carcinoma, Human Papillomavirus and p16
    Gowda, Mala R.
    CLINICAL CANCER INVESTIGATION JOURNAL, 2018, 7 (02): : 85 - 85
  • [28] Sexual Behavior, HPV Status and P16 Expression in Oropharyngeal and Oral Cavity Squamous Cell Carcinoma Patients
    Emmett, Sarah
    Boros, Sam
    Whiteman, David C.
    Porceddu, Sandro
    Panizza, Benedict
    Antonsson, Annika
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 92 - 92
  • [29] Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma
    Groebe, Alexander
    Hanken, Henning
    Kluwe, Lan
    Schoellchen, Maximilian
    Tribius, Silke
    Pohlenz, Philipp
    Clauditz, Till
    Grob, Tobias
    Simon, Ronald
    Sauter, Guido
    Heiland, Max
    Blessmann, Marco
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (09) : 676 - 681
  • [30] P16/Rb Pathway in Oropharyngeal Squamous Cell Carcinoma
    Tuluc, M.
    Bar-Ad, V.
    Cognetti, D.
    LABORATORY INVESTIGATION, 2012, 92 : 317A - 317A